Cost of Goods Sold: The difference between beginning and ending inventories for tangible products, resulting in an expense that reflects production and sales costs.
Edwards Lifesciences Corporation (EW) had Cost of Goods Sold of $392.40M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$1.74B |
|
$241.90M |
|
|
Cost of Goods Sold |
$392.40M |
$1.35B |
|
$1.23B |
|
$513.20M |
|
$6.60M |
|
$519.80M |
|
$559.80M |
|
$241.40M |
|
$241.40M |
|
$241.40M |
|
$302.82M |
|
$513.20M |
|
$555.90M |
|
576.40M |
|
577.60M |
|
$0.42 |
|
$0.42 |
|
| Balance Sheet Financials | |
$6.82B |
|
$1.84B |
|
$7.05B |
|
$13.87B |
|
$1.51B |
|
$598.70M |
|
$1.63B |
|
$3.14B |
|
$10.72B |
|
$7.39B |
|
$10.72B |
|
576.60M |
|
| Cash Flow Statement Financials | |
$695.70M |
|
$-286.00M |
|
$-451.50M |
|
$2.94B |
|
$2.91B |
|
$-29.80M |
|
$87.60M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.52 |
|
-- |
|
-- |
|
0.05 |
|
0.06 |
|
77.46% |
|
29.48% |
|
29.48% |
|
-- |
|
29.86% |
|
13.89% |
|
$563.90M |
|
-- |
|
-- |
|
-- |
|
0.13 |
|
0.35 |
|
1.82 |
|
49.40 |
|
2.25% |
|
3.27% |
|
1.74% |
|
2.13% |
|
$18.60 |
|
$0.98 |
|
$1.20 |
|